Edition:
United Kingdom

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

10.83USD
17 May 2019
Change (% chg)

-- (--)
Prev Close
$10.83
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
297,979
52-wk High
$20.85
52-wk Low
$9.51

About

Alder BioPharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize genetically engineered therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder's lead pivotal-stage product candidate, eptinezumab, is being evaluated... (more)

Overall

Beta: 2.82
Market Cap(Mil.): $904.35
Shares Outstanding(Mil.): 83.50
Dividend: --
Yield (%): --

Financials

  ALDR.OQ Industry Sector
P/E (TTM): -- 101.85 55.51
EPS (TTM): -4.78 -- --
ROI: -63.76 7.41 11.59
ROE: -145.22 7.88 16.33

Earnings vs. Estimates